ArticleThe clinical respiratory journal2026
Association Between Volatile Organic Compound Metabolites in Urine and Adult Lung Function: Evidence From NHANES 2011-2012.
Article in The clinical respiratory journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectivesVolatile organic compounds (VOCs) have been reported to be associated with adverse respiratory outcomes during daily exposure at low levels. However, the main contributors among the numerous VOCs and tobacco as the possible sources of VOCs in the general population have not been fully revealed. Here, we aimed to examine the association between urinary VOCs metabolites (UM-VOCs) mixtures and adult lung health.
methodsWe used data from the National Health and Nutrition Examination Survey (NHANES) for the years 2011-2012 and aimed at 16 UM-VOCs. Initially, we used linear regression to evaluate the association between a single compound and lung health. Next, we utilized the BKMR model to assess the overall effect and attempt to understand the potential modifying effects of smoking.
resultsOur linear regression analysis suggested that the majority of the UM-VOCs were inversely related to lung function. In multivariable linear regression models, each one-unit increase in natural log-transformed urinary concentrations (μg/mmol Cr) of AMCC, CYMA, MHBMA3, 3HPMA, AAMA, and MA was associated with an absolute decrease in 1 s/forced vital capacity (FEV1/FVC) ratio of 3.5, 1.6, 2.3, 3.0, 3.2, and 4.6 percentage points, respectively (all p < 0.05). Moreover, 3HPMA and HPMMA were positively correlated with wheeze symptom, while 2MHA and 3MHA + 4MHA were negatively correlated with fractional exhaled nitric oxide (FeNO), respectively. BKMR model results showed that UM-VOC mixtures exhibited a negative correlation with FEV1/FVC and FeNO. Urinary AMCC and CYMA were identified as the most important contributors to the decline in FEV1/FVC and FeNO, respectively. Subsequently, we found UM-VOCs of higher concentration in smokers, and stratified BKMR analyses revealed an effect modification by smoking status.
conclusionsUsing BKMR, we found that higher concentrations of urinary metabolites of VOCs (UM-VOCs) were associated with lower FEV
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.